ClinConnect ClinConnect Logo
Search / Trial NCT05866107

App and Body Fat Scale in the Management of Overweight Patients

Launched by CAPITAL MEDICAL UNIVERSITY · May 18, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how a health app and a smart body fat scale can help people who are overweight manage their weight better. The main goal is to see if using these tools regularly can help people lose weight and stay engaged with their health. Researchers will compare participants who use the app and scale consistently with those who do not, to understand how sticking to this program affects weight loss over time.

To be eligible for this study, participants should be between 18 and 60 years old, have a diagnosis of schizophrenia or bipolar disorder that is stable, and be currently overweight or obese. They should also be willing to use the app and scale to track their weight. Participants will need to understand how to use a smartphone and the smart scale. It's important to know that those planning to lose weight through other methods, or with certain health issues, may not qualify. If you join this study, you can expect to regularly monitor your weight and receive support through the app, while helping researchers understand how effective this approach can be for weight management.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18-60 years old, no gender restriction.
  • According to ICD-10 to diagnose bipolar disorder or schizophrenia, the researcher judges that the patient is currently in remission, or the condition is stable and can cooperate with the research.
  • Currently using at least one antipsychotic or mood stabilizer (e.g. lithium, magnesium valproate, sodium valproate, lamotrigine).
  • Currently overweight or obese (body mass index ≥ 24kg/m2) and willing to use health app and smart scales to lose weight.
  • The education level of primary school or above, able to understand the content of the scale, and be able to use smart phone proficiently.
  • Understand and voluntarily participate in this study, and sign the informed consent form.
  • Exclusion Criteria:
  • Plan to lose weight by other methods during the study period (such as dieting, inducing vomiting, taking diet pills, surgery).
  • Self-reported weight loss ≥ 7% in the past 6 months.
  • Weight over 150 kg.
  • Other secondary obesity (such as hypothyroidism, Cushing's syndrome, hypothalamic obesity, etc.).
  • Currently pregnant, lactating, \< 6 months postpartum or planning to become pregnant during the study period.
  • Self-reported cardiac discomfort or chest pain during activity or at rest.
  • There is a serious medical condition, and the researchers believe that there may be safety risks when participating in sports.
  • Be unable to walk 30 minutes without stopping.
  • There are problems that may affect compliance with the protocol (eg, end-stage disease, planning to move travel to the field, history of substance abuse, other uncontrolled or untreated medical conditions);
  • Any other conditions deemed inappropriate by the investigator.
  • Participants include approximately 50% with schizophrenia and 50% with bipolar disorder, distributed across all clusters.

About Capital Medical University

Capital Medical University is a leading institution in medical education and research, dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with a network of healthcare professionals and researchers to drive breakthroughs in medical science. Capital Medical University aims to enhance patient care and improve health outcomes by fostering a multidisciplinary approach to clinical research, ensuring that its trials are designed to address critical health challenges and contribute valuable insights to the medical community.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Le Xiao

Study Chair

Capital Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported